We initiated this project because it was clear from breast tumour RNA‐Seq data that there were both exons and alternative splicing events in the ESR1 locus that were not present in GENCODE or RefSeq, the main transcript annotation databases. This evidence concerns the gene ESR1 and breast neoplasm.